Chard Daniel R
Director at MED; Pres Global Sales & Operations at NUS
- Sold, on record
- $29.2M
- Dollars the filings state
- Form 4 sales
- 18
- Latest Sep 29, 2026
- Form 144 notices
- 2
- Proposed sales
- Companies
- 2
- Filed as an executive or holder
Companies
Sales by reason
1
Routine
5
Plan not stated
0
No plan
12
Unusual
Form 4 sales per year, every sale on record.
Sales by company
Shares sold, every Form 4 sale on record.
Timeline
- Sep 29, 2026Routine
Sold 12.8% of their holdings
$226k19,089 shares at $11.86
- Sep 29, 2026Notice
Filed a notice to sell 9,544 shares
$112k9,544 shares
- Sep 28, 2026Notice
Filed a notice to sell 9,545 shares
$114k9,545 shares
- Jun 17, 2021Plan not stated
Sold 5.6% of their holdings
$1.7M6,365 shares at $263.55
- Jun 16, 2021Plan not stated
Sold 10.7% of their holdings
$3.8M13,520 shares at $278.00
- Jun 14, 2021Plan not stated
Sold 10.7% of their holdings
$4.3M15,115 shares at $285.21
- Jul 6, 2015Unusual
Sold 26.7% of their holdings
$817k17,500 shares at $46.67
- Dec 2, 2013Unusual
Sold 65.7% of their holdings
$9.1M72,500 shares at $125.39
- Feb 13, 2013Unusual
Sold 53.4% of their holdings
$2.1M50,000 shares at $42.71
- Jun 21, 2011Unusual
Sold 28.1% of their holdings
$380k10,000 shares at $38.00
10 of 20
Every transaction
| Traded | Filed | Stock | Role | What | Amount | Price | Value | Held after | Source |
|---|---|---|---|---|---|---|---|---|---|
| Sep 29, 2026 | Sep 30, 2026 | MED | Director | Sold | 19,089 | $11.86 | $226k | 130,609 | SEC |
| Mar 25, 2026 | Mar 27, 2026 | MED | Chairman & CEO | Withheld for tax | 29,808 | $9.64 | $287k | 146,438 | SEC |
| Mar 25, 2026 | Mar 27, 2026 | MED | Chairman & CEO | Awarded | 41,795 | 188,233 | SEC | ||
| Mar 20, 2026 | Mar 27, 2026 | MED | Chairman & CEO | Bought | 17,678 | $10.11 | $179k | 17,678 | SEC |
| Jun 13, 2025 | Jun 17, 2025 | MED | Chairman & CEO | Bought | 381 | $13.13 | $5k | 149,698 | SEC |
| Mar 25, 2025 | Mar 27, 2025 | MED | Chairman & CEO | Awarded | 124,953 | 176,246 | SEC | ||
| Mar 17, 2025 | Mar 18, 2025 | MED | Chairman & CEO | Withheld for tax | 7,809 | $13.99 | $109k | 51,293 | SEC |
| Dec 3, 2024 | Feb 11, 2025 | MED | Chairman & CEO | Gift | 597,269 | 149,317 | SEC | ||
| Mar 15, 2024 | Mar 19, 2024 | MED | Chairman & CEO | Withheld for tax | 3,409 | $36.61 | $125k | 99,821 | SEC |
| Mar 13, 2024 | Mar 15, 2024 | MED | Chairman & CEO | Awarded | 45,087 | 103,230 | SEC | ||
| Feb 14, 2024 | Feb 16, 2024 | MED | Chairman & CEO | Withheld for tax | 5,471 | $52.68 | $288k | 58,143 | SEC |
| Feb 14, 2024 | Feb 16, 2024 | MED | Chairman & CEO | Awarded | 16,486 | 63,614 | SEC | ||
| Mar 17, 2023 | May 1, 2023 | MED | Chairman & CEO | Withheld for tax | 17,873 | $109.22 | $2M | 30,321 | SEC |
| Mar 17, 2023 | May 1, 2023 | MED | Chairman & CEO | Awarded | 50,883 | 47,128 | SEC | ||
| Feb 21, 2023 | Feb 22, 2023 | MED | Chairman & CEO | Withheld for tax | 1,815 | $115.31 | $209k | 14,118 | SEC |
| May 5, 2022 | May 11, 2022 | MED | Chairman & CEO | Bought | 431 | $183.25 | $79k | 108,598 | SEC |
| Mar 21, 2022 | Apr 21, 2022 | MED | Chairman & CEO | Gift | 8,656 | 108,167 | SEC | ||
| Mar 17, 2022 | Mar 21, 2022 | MED | Chairman & CEO | Withheld for tax | 878 | $180.52 | $158k | 20,261 | SEC |
| Mar 16, 2022 | Mar 21, 2022 | MED | Chairman & CEO | Awarded | 8,509 | 21,139 | SEC | ||
| Feb 22, 2022 | Feb 24, 2022 | MED | Chairman & CEO | Withheld for tax | 3,086 | $177.06 | $546k | 12,630 | SEC |
| Feb 4, 2022 | Apr 21, 2022 | MED | Chairman & CEO | Bought | 690 | $186.40 | $129k | 103,839 | SEC |
| Jan 3, 2022 | Jan 4, 2022 | MED | Chairman & CEO | Gift | 25,078 | 103,149 | SEC | ||
| Dec 31, 2021 | Jan 4, 2022 | MED | Chairman & CEO | Exercised options | 24,072 | 39,788 | SEC | ||
| Dec 31, 2021 | Jan 4, 2022 | MED | Chairman & CEO | Withheld for tax | 11,533 | $209.43 | $2.4M | 28,255 | SEC |
| Nov 4, 2021 | Nov 23, 2021 | MED | Chairman & CEO | Gift | 181,220 | 90,610 | SEC | ||
| Jun 17, 2021 | Jun 21, 2021 | MED | Chairman & CEO | Sold | 6,365 | $263.55 | $1.7M | 106,326 | SEC |
| Jun 16, 2021 | Jun 17, 2021 | MED | Chairman & CEO | Sold | 13,520 | $278.00 | $3.8M | 112,691 | SEC |
| Jun 14, 2021 | Jun 15, 2021 | MED | Chairman & CEO | Sold | 15,115 | $285.21 | $4.3M | 126,211 | SEC |
| Mar 17, 2021 | Mar 19, 2021 | MED | Chairman & CEO | Awarded | 5,495 | 141,326 | SEC | ||
| Feb 20, 2021 | Feb 23, 2021 | MED | Chief Executive Officer | Withheld for tax | 3 | $268.23 | $845 | 135,831 | SEC |
| Feb 20, 2020 | Feb 21, 2020 | MED | Chief Executive Officer | Withheld for tax | 1,348 | $101.45 | $137k | 137,974 | SEC |
| Feb 19, 2020 | Feb 21, 2020 | MED | Chief Executive Officer | Awarded | 10,172 | 139,142 | SEC | ||
| Dec 31, 2019 | Jan 3, 2020 | MED | Chief Executive Officer | Exercised or settledPerformance Stock Units | 210,000 | 0 | SEC | ||
| Dec 31, 2019 | Jan 3, 2020 | MED | Chief Executive Officer | Exercised options | 210,000 | 228,930 | SEC | ||
| Dec 31, 2019 | Jan 3, 2020 | MED | Chief Executive Officer | Withheld for tax | 99,960 | $109.58 | $11M | 128,970 | SEC |
| Oct 3, 2019 | Oct 4, 2019 | MED | Chief Executive Officer | Withheld for tax | 1,847 | $101.25 | $187k | 18,930 | SEC |
| Feb 20, 2019 | Feb 22, 2019 | MED | Chief Executive Officer | Awarded | 8,024 | 20,777 | SEC | ||
| Nov 8, 2018 | Nov 13, 2018 | MED | Chief Executive Officer | Bought | 975 | $153.28 | $149k | 12,753 | SEC |
| Oct 3, 2018 | Oct 4, 2018 | MED | Chief Executive Officer | Withheld for tax | 2,142 | $220.10 | $471k | 11,778 | SEC |
| Oct 3, 2017 | Oct 5, 2017 | MED | Chief Executive Officer | Withheld for tax | 2,141 | $59.70 | $128k | 13,920 | SEC |
| Oct 3, 2016 | Oct 4, 2016 | MED | Chief Executive Officer | AwardedPerformance-based deferred shares | 210,000 | 210,000 | SEC | ||
| Oct 3, 2016 | Oct 4, 2016 | MED | Chief Executive Officer | Awarded | 16,061 | 16,061 | SEC | ||
| Jul 6, 2015 | Jul 8, 2015 | NUS | Pres Global Sales & Operations | Sold | 17,500 | $46.67 | $817k | 48,111 | SEC |
| Jul 6, 2015 | Jul 8, 2015 | NUS | Pres Global Sales & Operations | Exercised or settledEmployee Stock Option (right to buy) | 17,500 | 0 | SEC | ||
| Jul 6, 2015 | Jul 8, 2015 | NUS | Pres Global Sales & Operations | Exercised options | 17,500 | $17.03 | $298k | 65,611 | SEC |
| Mar 10, 2015 | Mar 12, 2015 | NUS | Pres Global Sales & Operations | AwardedEmployee Stock Option (right to buy) | 6,800 | 6,800 | SEC | ||
| Mar 2, 2015 | Mar 4, 2015 | NUS | Pres Global Sales & Operations | Withheld for tax | 2,268 | $52.45 | $119k | 48,169 | SEC |
| Feb 28, 2015 | Mar 3, 2015 | NUS | Pres Global Sales & Operations | Exercised or settledEmployee Stock Option (right to buy) | 27,500 | 0 | SEC | ||
| Feb 28, 2015 | Mar 3, 2015 | NUS | Pres Global Sales & Operations | Exercised options | 27,500 | $18.87 | $519k | 65,828 | SEC |
| Feb 28, 2015 | Mar 3, 2015 | NUS | Pres Global Sales & Operations | Withheld for tax | 15,391 | $54.18 | $834k | 50,437 | SEC |
Page 1
Sales and notices (20)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Sep 29, 2026 | Sep 30, 2026 | MED | Director | Form 4 sale | 19,089 | $226k | 12.8% | Routine | SEC |
| Sep 29, 2026 | Sep 29, 2026 | MED | Director | Form 144 notice | 9,544 | $112k | Notice | SEC | |
| Sep 28, 2026 | Sep 28, 2026 | MED | Director | Form 144 notice | 9,545 | $114k | Notice | SEC | |
| Jun 17, 2021 | Jun 21, 2021 | MED | Chairman & CEO | Form 4 sale | 6,365 | $1.7M | 5.6% | Plan not stated | SEC |
| Jun 16, 2021 | Jun 17, 2021 | MED | Chairman & CEO | Form 4 sale | 13,520 | $3.8M | 10.7% | Plan not stated | SEC |
| Jun 14, 2021 | Jun 15, 2021 | MED | Chairman & CEO | Form 4 sale | 15,115 | $4.3M | 10.7% | Plan not stated | SEC |
| Jul 6, 2015 | Jul 8, 2015 | NUS | Pres Global Sales & Operations | Form 4 sale | 17,500 | $817k | 26.7% | Unusual | SEC |
| Dec 2, 2013 | Dec 4, 2013 | NUS | President | Form 4 sale | 72,500 | $9.1M | 65.7% | Unusual | SEC |
| Feb 13, 2013 | Feb 14, 2013 | NUS | President | Form 4 sale | 50,000 | $2.1M | 53.4% | Unusual | SEC |
| Jun 21, 2011 | Jun 24, 2011 | NUS | President | Form 4 sale | 10,000 | $380k | 28.1% | Unusual | SEC |
| Jun 16, 2011 | Jun 20, 2011 | NUS | President | Form 4 sale | 25,000 | $914k | 49.4% | Unusual | SEC |
| Jun 13, 2011 | Jun 14, 2011 | NUS | President | Form 4 sale | 38,750 | $1.4M | 60.2% | Unusual | SEC |
| May 2, 2011 | May 3, 2011 | NUS | President | Form 4 sale | 5,000 | $161k | 17.4% | Plan not stated | SEC |
| Feb 1, 2011 | Feb 3, 2011 | NUS | President | Form 4 sale | 10,000 | $301k | 29.6% | Unusual | SEC |
| Nov 1, 2010 | Nov 3, 2010 | NUS | President | Form 4 sale | 30,000 | $904k | 55.7% | Unusual | SEC |
| Oct 21, 2010 | Oct 22, 2010 | NUS | President | Form 4 sale | 2,706 | $82k | 10.2% | Plan not stated | SEC |
| Oct 6, 2010 | Oct 7, 2010 | NUS | President | Form 4 sale | 30,000 | $885k | 55.7% | Unusual | SEC |
| Jul 27, 2010 | Aug 3, 2010 | NUS | President | Form 4 sale | 11,628 | $347k | 32.8% | Unusual | SEC |
| Mar 8, 2010 | Mar 10, 2010 | NUS | President | Form 4 sale | 58,058 | $1.7M | 73.2% | Unusual | SEC |
| Jan 6, 2010 | Jan 7, 2010 | NUS | President | Form 4 sale | 5,208 | $142k | 40.6% | Unusual | SEC |